Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Castle Biosciences Inc., 3 years.
Castle Biosciences Inc.
Director
MiMedx Group Inc
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
MiMedx Group Inc June 10, 202697.1%
-
Castle Biosciences Inc. May 28, 202663.7%
-
MiMedx Group Inc June 18, 202595.1%
-
MiMedx Group Inc June 5, 202495.5%
-
Castle Biosciences Inc. May 25, 202391.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 10, 2026 | MiMedx Group Inc | Grant or award | +50,913 | $3.64 | $185,323 |
| May 22, 2026 | Castle Biosciences Inc. | Option exercise | +13,667 | — | — |
| Jun 18, 2025 | MiMedx Group Inc | Grant or award | +28,609 | $6.47 | $185,100 |
| May 21, 2025 | Castle Biosciences Inc. | Option exercise | +8,673 | — | — |
| Jul 1, 2024 | Castle Biosciences Inc. | Option exercise | +830 | — | — |
| Jun 5, 2024 | MiMedx Group Inc | Grant or award | +28,988 | $7.26 | $210,453 |
| May 25, 2024 | Castle Biosciences Inc. | Option exercise | +8,636 | — | — |
| May 10, 2024 | Castle Biosciences Inc. | Option exercise | +487 | — | — |
| Jun 2, 2023 | Castle Biosciences Inc. | Option exercise | +3,825 | — | — |
| May 10, 2023 | Castle Biosciences Inc. | Option exercise | +487 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.